PHARMA
Servier, A*STAR To Develop Drugs That Target Immune System
French pharmaceutical company Servier has inked three Research Collaboration Agreements with A*STAR's Singapore Immunology Network.
Servier To License Lucitanib To SIMM In China
Servier and the Shanghai Institute of Materia Medica will collaborate on the development of lucitanib, a targeted antitumor drug candidate with anti-angiogenic effects, in China.
Ironwood, AstraZeneca Initiate Linaclotide PhIII Trial In China
Ironwood and AstraZeneca have initiated a Phase III clinical trial of linaclotide for the treatment of adults with irritable bowel syndrome with constipation.
Norgine, Takeda Receive NDA Approval For OBLEAN Tablets 120mg In Japan
The Japanese Ministry of Health, Labor and Welfare has approved an NDA for OBLEAN® Tablets 120mg for the treatment of obesity with complications.
McLaren Applied Technologies Opens APAC HQ In Singapore
McLaren Applied Technologies has established the headquarters of its Asia Pacific operations in Singapore.
Otsuka Pharma To Acquire Astex Pharma For US$866m
Otsuka Pharma has acquired Astex Pharma via an all-cash tender offer of US$866 million.
Bharat Biotech Launches Typhoid Conjugate Vaccine
Bharat Biotech has launched the world's first typhoid vaccine that can be given to infants older than six months.
Covidien Opens US$21m R&D Facility In South Korea
Healthcare provider Covidien today announced the opening of the Covidien Center of Innovation Korea, its first R&D and training & education center in Korea.
Adimab Partners Innovent On Monoclonal Antibody Drug Research
Adimab, LLC and Innovent have signed a partnership for the discovery, development and commercialization of an antibody-based therapeutic program.
